CYTOGENETIC STRUCTURE OF ANEUPLOID BLOOD CULTURE CELL POPULATIONS DURING PROGRESSION AND TREATMENT OF CHRONIC MYELOGENOUS LEUKAEMIA

被引：0
|
作者：
PEDERSEN, B
机构：
来源：
ACTA PATHOLOGICA ET MICROBIOLOGICA SCANDINAVICA | 1967年 / 69卷 / 02期
关键词：
D O I：
暂无
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：192 / &
相关论文
共 50 条
  • [21] CHANGES IN STROMAL PROGENITOR CELLS DERIVED FROM BONE MARROW IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKAEMIA AT THE ONSET OF THE DISEASE AND DURING TREATMENT
    Petinati, N. A.
    Shipunova, I. N.
    Bigildeev, A. E.
    Sats, N., V
    Yu, Chelysheva E.
    Shukhov, O. A.
    Petrova, A. N.
    Turkina, A. G.
    Drize, N., I
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2019, 64 (04): : 424 - 435
  • [22] Limited efficacy of HLA-haploidentical peripheral blood stem cell infusion in treatment of elderly patients with acute myelogenous leukaemia
    Sustkova, Zuzana
    Jeziskova, Ivana
    Dvorakova, Dana
    Horky, Ondrej
    Semerad, Lukas
    Weinbergerova, Barbora
    Culen, Martin
    Mayer, Jiri
    Racil, Zdenek
    HEMATOLOGICAL ONCOLOGY, 2017, 35 (02) : 244 - 245
  • [23] Imatinib mesylate (STI571) treatment in patients with chronic-phase chronic myelogenous leukaemia previously submitted to autologous stem cell transplantation
    Cervantes, F
    Hernández-Boluda, JC
    Odriozola, J
    Camós, M
    Villalón, L
    Martínez-Climent, JA
    Del Campo, R
    García-Conde, J
    Montserrat, E
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 120 (03) : 500 - 504
  • [24] Kinetics of versican-expressing macrophages in bone marrow after cord blood stem cell transplantation for treatment of acute myelogenous leukaemia
    Senda, Miho
    Fukuyama, Ryuichi
    Nagasaka, Tetsuro
    JOURNAL OF CLINICAL PATHOLOGY, 2016, 69 (10) : 906 - 911
  • [25] Quality of peripheral blood stem cells collected from patients in complete cytogenetic remission of chronic myeloid leukaemia after imatinib mesylate treatment
    Marin, P
    Carrió, A
    Colomer, D
    Lozano, M
    Carreras, E
    Petriz, J
    Cervantes, F
    Ordinas, A
    Montserrat, E
    BONE MARROW TRANSPLANTATION, 2003, 31 : S165 - S165
  • [26] Chronic myelogenous leukemia in mast cell blast crises after having reached morphological, cytogenetic, and molecular remission after imatinib treatment.
    Vence, NNAVA
    Encinas, MMPEP
    López, AABLB
    Martínez, MJMJRMR
    López, JLJLBLB
    Devesa, JJDJ
    BLOOD, 2003, 102 (11) : 248B - 248B
  • [27] EFFECTS OF TAXOL ON ACUTE MYELOGENOUS LEUKEMIA (AML) BLAST CELL-POPULATIONS - POTENTIAL OF CELL-CULTURE STUDIES FOR DEVELOPING NEW TREATMENT STRATEGIES
    CURTIS, JE
    MCCULLOCH, EA
    BLOOD, 1994, 84 (10) : A53 - A53
  • [28] Differential effect of interferon α on chronic myelogenous leukaemia and normal haematopoietic progenitors in a stromal cell co-culture context:: role of the flt3 ligand
    Solanilla, A
    El Andaloussi, A
    Grosset, C
    Duchez, P
    Mossalayi, MD
    Mahon, FX
    Reiffers, J
    Marit, G
    Ripoche, J
    BRITISH JOURNAL OF HAEMATOLOGY, 2000, 109 (02) : 382 - 387
  • [29] Peripheral blood stem cell transplantation (PBSCT) during consolidation treatment of de novo acute myelogenous leukemia
    Reichle, A
    Hennemann, B
    Meidenbauer, N
    Zaiss, M
    Bross, KJ
    Andreesen, R
    BLOOD, 1996, 88 (10) : 3874 - 3874
  • [30] Peripheral blood stem cell transplantation (PBSCT) during consolidation treatment of de novo acute myelogenous leukemia
    Reichle, A
    Hennemann, B
    Meidenbauer, N
    Zaiss, M
    Bross, KJ
    Andreesen, R
    BONE MARROW TRANSPLANTATION, 1998, 22 : S8 - S8
12345